Analyst Sentiment on Certara (CERT) Remains Moderately Bullish Despite Sector Volatility

Certara, Inc. (NASDAQ:CERT) is one of the 14 oversold value stocks to invest in right now.

Certara, Inc. (NASDAQ:CERT) enjoys the confidence of 60% of analysts as of February 5, 2026, who remain bullish on the stock. The consensus price target of $12.00 implies a 57.70% upside potential.

Certara, Inc. (NASDAQ:CERT) drew attention from KeyBanc on January 8, 2026. The firm reduced its price target on the stock from $13 to $12 and reiterated its ‘Overweight’ rating. While highlighting the volatile year the Healthcare Information Technology industry faced, the firm believes Certara is showing a year of inflection, citing fundamental momentum that is expected to continue. Although the firm said valuation multiples are under pressure amid competition and regulatory headwinds, it projects upside once market conditions cool.

Meanwhile, on January 6, 2026, Leerink upgraded Certara, Inc. (NASDAQ:CERT) from ‘Market Perform’ to ‘Outperform’, while keeping the $13 price target unchanged. The firm’s bullish stance stems from the company’s leadership role in the broad-based biosimulation market. The company’s shares faced pressure in late 2025 amid softer Q3 services bookings, biopharma budget delays, and the CEO change. However, the firm described the selloff as an overreaction, expecting improving market dynamics to accelerate the company’s growth in 2026.

Certara, Inc. (NASDAQ:CERT) focuses on offering software and technology-enabled services for drug developers. The services include modeling, decision analytics, clinical pharmacology, complex biologics, and regulatory strategy solutions.

While we acknowledge the potential of CERT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: What Are the Best Stocks to Buy Right Now? and 10 Stocks Under $1 That Will Explode.

Disclosure: None.